Kevin 'O''Brien''s Colleagues at Inozyme Pharma
Kevin 'O''Brien''s Contact Details
HQ
857-330-4340
857-330-4340
Location
Company
Inozyme Pharma
Inozyme Pharma
Kevin 'O''Brien''s Company Details
We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.
Frequently Asked Questions about Kevin 'O''Brien'
Kevin 'O''Brien' currently works for Inozyme Pharma.
Kevin 'O''Brien''s role at Inozyme Pharma is Senior Scientist.
Kevin 'O''Brien''s email address is ***@inozyme.com. To view Kevin 'O''Brien''s full email address, please signup to ConnectPlex.
Kevin 'O''Brien' works in the Biotechnology industry.
Kevin 'O''Brien''s colleagues at Inozyme Pharma are Jennifer Howe, Katie PharmD, Daniel Michaels, Bridget McNamara, Caitlin Sullivan, David Thompson, Stephen Basso and others.
Kevin 'O''Brien''s phone number is 857-330-4340